Coronary angiography and angioplasty after acute myocardial infarction

Annals of Internal Medicine

Volumn 126, Issue 7, 1997, Pages 539-550

  Bates, David W ^a   Miller, Elizabeth ^a   Bernstein, Steven J ^b   Hauptman, Paul J ^a   Leape, Lucian L ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANGIOPLASTY; BLOOD CLOT LYSIS; COST BENEFIT ANALYSIS; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE SEPTUM DEFECT; MEDICAL LITERATURE; MITRAL VALVE REGURGITATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; THORAX PAIN; TREATMENT OUTCOME;

EID: 0030989070     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-7-199704010-00007     Document Type: Review

References (121)

1. Rogers WJ, Topol EJ. The role of angiography. In: Fuster V, ROSS R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. New York: Lippincott-Raven; 1996.
2. Verrilli D, Welch HG. The impact of diagnostic testing on therapeutic interventions. JAMA. 1996;275:1189-91.
3. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. 1986;314:512-4.
4. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476-85.
5. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993;328:673-9.
6. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328: 680-4.
7. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993;328:685-91.
8. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J Jr, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-8.
9. DeWood MA, Fisher MJ. Direct PTCA versus intravenous rtPA in acute myocardial infarction: preliminary results from a prospective randomized trial. Spokane Heart Research Group. Circulation. 1989;80:11-418.
10. De Boer M, Hoorntje J, Suryapranata H, Zijlstra F. Coronary angioplasty results in a lower rate of recurrent infarction and death when compared with streptokinase in patients with a myocardial infarction. Circulation. 1993;88: 1-106.
11. Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1993;22: 376-80.
12. Elizaga J, Garcia EJ, Dekan JL, Garcia-Robles JA, Bueno H, Soriano J, et al. Primary coronary angioplasty versus systemic thrombolysis m acute anterior myocardial infarction: in-hospital results from a prospective randomized trial. Circulation. 1993;88:1-411.
13. Brodie BR, Weintraub RA, Stuckey TD, LeBauer EJ, Katz JD, Kelly TA, et al. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol 1991;67:7-12
14. Himbert D, Juliard JM, Steg PG, Badaoui G, Baleynaud S, Le Guludec D, et al. Primary coronary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol. 1993;71:377-8l.
15. Stone GW, Rutherford BD, McConahay DR, Johnson WL Jr, Giorgi LV, Ligon RW, et al. Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease. J Am Coll Cardiol. 1990;15: 534-43.
16. Erbel R, Pop T, Henrichs KJ, von Olshausen K, Schuster CJ, Rupprecht HJ, et al. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol. 1986; 8:485-95.
17. Erbel R, Pop T, Diefenbach C, Meyer J. Long-term results of thrombolytic therapy with and without percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1989;14:276-85.
18. Simoons ML, Arnold AE, Betriu A, de Bono DP, Col J, Dougherty FC, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988;1:197-203.
19. Arnold AE, Simoons ML, Van de Werf F, de Bono DP, Lubsen J, Tijssen JG, et al. Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study Group. Circulation. 1992;86:111-20.
20. Topol EJ, O'Neill WW, Langburd AB, Walton JA Jr, Bourdillon PD, Bates ER, et al. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation. 1987;75: 420-8.
21. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II-A results. The TIMI Research Group. JAMA. 1988;260:2849-58.
22. Guerci AD, Gerstenblith G, Brinker JA, Chandra NC, Gottlieb SO, Bahr RD, et al. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty. N Engl J Med. 1987;317:1613-8.
23. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27.
24. Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, et al. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation. 1992;85:533-42.
25. Neskovic AN, Popovic AD, Babic R, Marinkovic J, Obradovic V. Positive high-dose dipyridamole echocardiography test after acute myocardial infarction is an excellent predictor of cardiac events. Am Heart J. 1995;129:31-9.
26. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation. 1992;85:1254-64.
27. Topol EJ, Ellis SG, Wall TC, George BS, Vandormael M, Grines CL, et al. A randomized, controlled trial of late (6-24 hour) reperfusion for acute myocardial infarction. Circulation. 1990;82:III-539.
28. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, et al. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation. 1992;85:2090-9.
29. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. BMJ. 1991;302: 555-60.
30. Ellis SG, Ribeiro da Silva E, Hendrickx GR, Talley JD, Cernigliaro C, Steg G, et al. Final results of the randomized RESCUE study evaluating PTCA after failed thrombolysis for patients with anterior infarction. Circulation. 1993;88:l-106.
31. Belenkie I, Traboulsi M, Hall CA, Hansen JL, Roth DL, Manyari D, et al. Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis. Can J Cardiol. 1992;8:357-62.
32. Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990;81: 1457-76.
33. Baim DS, Braunwald E, Feit F, Knatterud GL, Passamani ER, Robertson TL, et al. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives. J Am Coll Cardiol. 1990;15:1188-92.
34. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction - phase 5 randomized trial. TAMI Study Group. Circulation. 1991;83:1543-56.
35. Muller DW, Topol EJ, Ellis SG, Woodlief LH, Sigmon KN, Kereiakes DJ, et al. Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction TAMI-5 Study Group J Am Coll Cardiol. 1991;18:1594-601.
36. Norris RM, Agnew TM, Brandt PW, Graham KJ, Hill DG, Kerr AR, et al. Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease Circulation. 1981;63:785-92.
37. Ozbek C, Dyckmans J, Sen S, Schieffer H. Comparison of invasive and conservative strategies after treatment with streptokinase in acute myocardial infarction: results of a randomized trial (SIAM). J Am Coll Cardiol. 1990; 15:63A.
38. Barbash Gl, Roth A, Hod H, Modan M, Miller HI, Rath S, et al. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:538-45.
39. Ellis SG, Mooney MR, George BS, da Silva EE, Talley JD, Flanagan WH, et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group. Circulation. 1992;86:1400-6.
40. van den Brand MJ, Betriu A, Lopez Bescos L, Nijssen K, Pfisterer ME, Renkin J, et al. Randomized trial of deferred angioplasty after thrombolysis for acute myocardial infarction. Coron Artery Dis. 1992;3:393-401.
41. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-54.
42. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343:311-22.
43. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group. Lancet. 1993;342:767-72.
44. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 1993;342:759-66.
45. Bernstein SJ, Laouri M, Hilborne LH, Leape LL, Kahan JP, Park RE, et al. Coronary Angiography: A Literature Review and Ratings of Appropriateness and Necessity. Santa Monica, CA: RAND; 1992.
46. Ellis S. The GUSTO IIb angioplasty substudy. Proceedings of the American College of Cardiology Scientific Sessions, March 27, 1996, Orlando, FL.
47. Rogers WJ, Dean LS, Moore PB, Wool KJ, Burgard SL, Bradley EL. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators. Am J Cardiol. 1994;74:111-8.
48. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med. 1996;335:1253-60.
49. DeWood MA, Berg R Jr. The role of surgical reperfusion in myocardial infarction. Cardiol Clin. 1984;2:113-22.
50. Koshal A, Beanlands DS, Davies RA, Nair RC, Keon WJ. Urgent surgical reperfusion in acute evolving myocardial infarction. A randomized controlled study. Circulation. 1988;78(3 Pt 2):1171-8.
51. Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, Rozenman Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985;313: 1384-9.
52. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'lnfarto Miocardico (GISSI). Lancet. 1986;1:397-402.
53. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993:270:1211-6.
54. Timm TC, Ross R, McKendall GR. Left ventricular function and early cardiac events as a function of time to treatment with t-PA: a report from TIM! II [Abstract]. Circulation. 1991;84:ll-230.
55. Ruocco NA Jr, Bergeisen BA, Jacobs AK, Frederick MM, Faxon DP, Ryan TJ. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II). J Am Coll Cardiol. 1992;20:1445-51.
56. Brown KA, Boucher CA, Okada RD, Newell J, Strauss HW, Pohost GM. Prognostic significance of regional myocardial ischemia of the ventricular septum assessed by thallium-201 exercise testing. Am J Cardiol. 1986; 58:359-60.
57. de Beider MA, Pumphrey CW, Skehan JD, Rimington H, al Wakeel B, Evans SJ, et al. Relative power of clinical, exercise test, and angiographic variables in predicting clinical outcome after myocardial infarction: the Newham and Tower Hamlets study. Br Heart J. 1988;60:377-89.
58. DeBusk RF, Davidson DM, Houston N, Fitzgerald J. Serial ambulatory electrocardiography and treadmill exercise testing after uncomplicated myocardial infarction. Am J Cardiol. 1980;45:547-54.
59. DeBusk RF, Kraemer HC, Nash E, Berger WE 3d, Lew H. Stepwise risk stratification soon after acute myocardial infarction. Am J Cardiol. 1983;52: 1161-6.
60. De Servi S, Vaccari L, Graziano G, Cornalba C, Codega S, Poma E, et al. Clinical and angiographic data in early post-infarction angina. Eur Heart J. 1986;7(Suppl C):69-72.
61. DeWood MA, Spores J, Berg R Jr, Kendall RW, Grunwald RP, Selinger SL, et al. Acute myocardial infarction: a decade of experience with surgical reperfuston in 701 patients. Circulation. 1983;68(3 Pt 2):II8-16.
62. Fuller CM, Raizner AE, Verani MS, Nahormek PA, Chahine RA, McEntee CW, et al. Early post-myocardial infarction treadmill stress testing. An accurate predictor of multivessel coronary disease and subsequent cardiac events. Ann Intern Med. 1981;94:734-9.
63. Geltman EM, Ehsani AA, Campbell MK, Schechtman K, Roberts R, Sobel BE. The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality. Circulation. 1979;60:805-14.
64. Mutter AM Jr, DeSanctis RW, Flynn T, Yeatman LA. Nontransmural myocardial infarction: a comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction. Am J Cardiol. 1981;48:595-602.
65. Krone RJ, Dwyer EM Jr, Greenberg H, Miller JP, Gillespie JA. Risk stratification in patients with first non-Q wave infarction: limited value of the early low level exercise test after uncomplicated infarcts. The Multicenter Post-Infarction Research Group. J Am Coll Cardiol. 1989;14:31-7.
66. Moss AJ, Davis HT, DeCamilla J, Bayer LW. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation. 1979;60:998-1003.
67. Murray DP, Murray RG, Rafiqi E, Littler WA. Routine exercise testing or thallium-201 scintigraphy for prediction of cardiac events post-myocardial infarction? Eur J Nucl Med. 1987;13:274-7.
68. Peart I, Odemuyiwa O, Albers C, Hall A, Kelly C, Hall RJ. Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years. Br Heart J. 1989;61:231-7.
69. Ross J Jr, Gilpin EA, Madsen EB, Henning H, Nicod P, Dittrich H, et al. A decision scheme for coronary angiography after acute myocardial infarction. Circulation. 1989;79:292-303.
70. Schulze RA Jr, Strauss HW, Pitt B. Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction. Am J Med. 1977; 62:192-9.
71. Schuster EH, Bulkley BH. Early post-infarction angina. Ischemia at a distance and ischemia in the infarct zone, N Engl J Med. 1981;305:1101-5.
72. Silverman KJ, Becker LC, Bulkley BH, Burow RD, Mellits ED, Kallman CH, et al. Value of early thalliurn-201 scintigraphy for predicting mortality in patients with acute myocardial infarction. Circulation. 1980;61:996-1003.
73. Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med. 1979;301:341-5.
74. Weld FM, Chu KL, Bigger JT Jr, Rolnitzky LM. Risk stratification with low-level exercise testing 2 weeks after acute myocardial infarction. Circulation. 1981;64:306-14.
75. Gardner TJ, Stuart RS, Greene PS, Baumgartner WA. The risk of coronary bypass surgery for patients with postinfarction angina. Circulation. 1989;79(6 Pt 2):179-80.
76. Jones EL, Waites TF, Craver JM, Bradford JM, Douglas JS, King SB, et al. Coronary bypass for relief of persistent pain following acute myocardial infarction. Ann Thorac Surg. 1981;32:33-43.
77. Silva P, Galli M, Campolo L. Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. IRES (Ischemia Residua) Study Group. Am J Cardiol. 1993;71:1142-7.
78. Gunnar RM, Passamani ER, Bourdillon PD, Pitt B, Dixon DW, Rapaport E, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1990;16:249-92.
79. Topol EJ, Holmes DR, Rogers WJ. Coronary angiography after thrombolytic therapy for acute myocardial infarction. Ann Intern Med. 1991;114: 877-85.
80. Juliard JM, Steg PG, Himbert D, Cohen-Solal A, Aumont MC, Gourgon R. A patency-oriented strategy for early management of acute myocardial infarction using emergency coronary angiography and selective coronary angioplasty. Am J Cardiol. 1992;69:1383-8.
81. Eckman MH, Wong JB, Salem DN, Pauker SG. Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets. Ann Intern Med. 1992;117:667-76.
82. O'Rourke RA. Management of patients after myocardial infarction and thrombolytic therapy. Curr Probl Cardiol. 1994;19:179-226.
83. Nashef SA, Carey F, Silcock MM, Oommen PK, Levy RD, Jones MT. Risk stratification for open heart surgery: trial of the Parsonnet system in a British hospital. BMJ. 1992;305:1066-7.
84. Kimmel SE, Berlin JA, Strom BL, Laskey WK. Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1995;26:931-8.
85. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-6
86. Muller DW, Topol EJ, Ellis SG, Sigmon KN, Lee K, Califf RM. Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty m Myocardial Infarction (TAMI) Study Group. Am Heart J. 1991; 121(4 Pt 1) 1042-9
87. Arnold AE, Simoons ML, Detry JM, von Essen R, Van de Werf F, Deckers JW, et al. Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? European Cooperative Study Group. Eur Heart J. 1993;14: 306-15.
88. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation. 1983;68:939-50.
89. Muller DW, Topol EJ, Califf RM, Sigmon KN, German L, George BS, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J. 1990;119(2 Pt 1):224-3l.
90. Krumholz HM, Friesinger GC, Cook EF, Lee TH, Rouan GW, Goldman L. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction. J Am Geriatr Soc. 1994;42:127-31.
91. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 1992;268:2530-6.
92. Chaitman BR, Younis LT, Shaw L. Exercise ECG test results in the TIMI II trial [Abstract]. J Am Coll Cardiol. 1990;15:251A.
93. Aguirre FV, Younis LT, Chaitman BR, Ross AM, McMahon RP, Kern MJ, et al. Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study. Circulation. 1995;91:2541-8.
94. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643-50.
95. Hilborne LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH. Percutaneous Transluminal Coronary Angioplasty: A Literature Review and Ratings of Appropriateness and Necessity. Santa Monica, CA: RAND; 1991.
96. Bittl JA. Advances in coronary angioplasty. N Engl J Med. 1996;335:1290-302.
97. Ellis SG, Miller DP, Brown KJ, Omoigui N, Howell GL, Kutner M, et al. In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications. Circulation. 1995;92:741-7.
98. Ellis SG, Omoigui N, Bittl JA, Lincoff M, Wolfe MW, Howell G, et al. Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures. Circulation. 1996;93:431-9.
99. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Engl J Med. 1980;303:89/-902.
100. Kennedy JW, Ritchie JL, Davis KB, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 1983;309:1477-82.
101. Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, et al. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med. 1984;311:1457-63.
102. Serruys PW, van den Brand M, Hooghoudt TE, Simoons ML, Fioretti P, Ruiter J, et al. Coronary recanalization in acute myocardial infarction: immediate results and potential risks. Eur Heart J. 1982;3:404-15.
103. Graves EJ. National Hospital Discharge Survey: annual summary, 1992. Vital Health Stat. 1994;Oct:1-63.
104. The DRG Handbook: Comparative Clinical and Financial Standards. Baltimore: HCIA; 1995.
105. Leape LL, Hilborne LH, Park RE, Bernstein SJ, Kamberg CJ, Sherwood M, et al. The appropriateness of use of coronary artery bypass graft surgery in New York State. JAMA. 1993;269:753-60.
106. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA. 1993;270:1832-6.
107. Rouleau JL, Moye LA, Pfeffer MA, Arnold JM, Bernstein V, Cuddy TE, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med. 1993;328:779-84.
108. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ, Granger CB. et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130-5.
109. Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, et al. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med. 1995;333:565-72.
110. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333:573-8.
111. 1992 hospital charges for two major surgical procedures for cardiovascular diseases. Part II: Cardiac catheterization. Stat Bull Metrop Insur Co. 1994; 75:21-8.
112. Beauchamp PK. Ambulatory cardiac cathetenzation cuts costs for hospital and patients. Hospitals. 1981;55:62-3.
113. Dietrich E, Kinard S, Pierce A. Outpatient cardiac catheterization and rtenography: twenty-month experience at the Arizona Heart Institute. Cardiovascular Disease Bulletin of the Texas Heart Institute. 1981;8:195-204.
114. Fierens E. Outpatient coronary artenography. Cathet Cardiovasc Diagn. 1984;10:27-32
115. Lee JC, Bengtson JR, Lipscomb J, Bashore TM, Mark DB, Califf RM, et al. Feasibility and cost-saving potential of outpatient cardiac catheterization. J Am Coll Cardiol 1990;15:378-84.
116. Mahrer PR, Eshoo N. Outpatient cardiac cathetenzation and coronary angiography. Cathet Cardiovasc Diaqn. 1981;7:355-60
117. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DW, Schork NJ, et al. Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation. 1993;87:1489-97
118. Charles ED, Rogers WJ, Reeder GS. Economic advantages of a conservative strategy for acute myocardial infarction management: rt-PA without obligatory PTCA [Abstract]. J Am Coll Cardiol. 1989;13:152A.
119. Lange RA, Hillis LD. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Thrombolysis - the preferred treatment. N Engl J Med. 1996;335:1311-2.
120. Grines CL. Should thrombolysis or primary angioplasty by the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice. N Engl J Med. 1996;335:1313-7
121. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolylic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996;348:771-5.